Interferon alpha-2: all 94 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- To Optimize the Therapeutic Pathway of Peginterferon Treatment in Patients With CHB Based on IFNA2p.Ala120Thr /ISGs.RecruitingNCT03771677Not applicable
- Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer PatientsTerminatedNCT04379518Phase 1/2Results posted
- Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory MelanomaTerminatedNCT04093323Phase 2Results posted
- Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast CancerCompletedNCT04081389Phase 1Results posted
- SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002)TerminatedNCT03552549Phase 2/3Results posted
- Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the LiverCompletedNCT03403634Phase 2Results posted
- A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical StudiesCompletedNCT02829775Phase 2/3Results posted
- Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC)TerminatedNCT02447887Phase 1/2Results posted
- Lonafarnib Boosted With Ritonavir With and Without Peginterferon Alfa-2a (PEG IFN-a) in HDV (LOWR-2)CompletedNCT02430194Phase 2Results posted
- Pilot Study of Interferon Alfa for Patients Who Have Received Cancer VaccinesTerminatedNCT02159482Phase 2Results posted
- Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT01708941Phase 2Results posted
- A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination StudyCompletedNCT01609933Phase 2Results posted
- A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) LymphomaCompletedNCT01609010Phase 3Results posted
- A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1CompletedNCT01479868Phase 3Results posted
- Recombinant Interferon Alfa-2b in Treating Patients With MelanomaCompletedNCT01460875Not applicableResults posted
- A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3CompletedNCT01364090Phase 4Results posted
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by SurgeryActive, not recruitingNCT01274338Phase 3Results posted
- Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone SurgeryCompletedNCT01158534Phase 2Results posted
- Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic ImbalanceCompletedNCT01100528Phase 2Results posted
- Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis CCompletedNCT00919633Phase 2Results posted
- Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/LymphomaTerminatedNCT00854581Phase 4Results posted
- A Study of Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC).CompletedNCT00796757Phase 2Results posted
- Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine TumorActive, not recruitingNCT00569127Phase 3Results posted
- Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell CarcinomaTerminatedNCT00561912Phase 2Results posted
- Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic TransplantationCompletedNCT00548847Phase 2Results posted
- Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk MelanomaActive, not recruitingNCT00539591Phase 2Results posted
- A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.CompletedNCT00520403Phase 2Results posted
- Pegasys® in Patients With Myeloproliferative DiseasesCompletedNCT00452023Phase 2Results posted
- Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical CancerTerminatedNCT00138151Phase 2Results posted
- Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney CancerCompletedNCT00126594Phase 2Results posted
- High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III MelanomaCompletedNCT00003641Phase 3Results posted
- Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19)CompletedNCT04988217Phase 1/2
- The Fleming [FMTVDM] Directed CoVid-19 Treatment ProtocolCompletedNCT04349410Phase 2/3
- Adoptive T Cell Therapy in Patients With Recurrent Ovarian CancerStatus unknownNCT04072263Phase 1/2
- Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before SurgeryActive, not recruitingNCT03899987Phase 2
- Optimal Treatment for Poor Efficacy of Entecavir in Chronic Hepatitis B PatientsStatus unknownNCT03733652Not applicable
- Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease UveitisCompletedNCT03209219Phase 3
- Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Chinese Healthy VolunteersCompletedNCT02781753Phase 1
- Phase I BP Interferon (IFN) Beta-004CompletedNCT02517788Phase 1
- Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B PatientsCompletedNCT02360592Phase 4
- Neoadjuvant Combination Biotherapy With Pembrolizumab and High Dose IFN-alfa2bCompletedNCT02339324Phase 1
- Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell LymphomasTerminatedNCT02323659Phase 4
- Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial NeoplasiaCompletedNCT02199327Phase 4
- Interferon α for the Therapy of Minimal Residual DiseaseStatus unknownNCT02185261Not applicable
- Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO)CompletedNCT02107365Phase 2
- Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase Ib Study in Chronic Hepatitis B PatientsCompletedNCT01997944Phase 1/2
- Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in MelanomaCompletedNCT01943422Phase 1
- Randomized Phase III of PRRT Versus InterferonWithdrawnNCT01860742Phase 3
- Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4CompletedNCT01686789Phase 4
- Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian CancerCompletedNCT01639885Phase 1/2
- Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian CancerCompletedNCT01637532Phase 1/2
- Multiple Antigen-Engineered DC Vaccine for MelanomaCompletedNCT01622933Phase 1
- Pazopanib in Combination With Interferon Alfa 2-A, in Patients With Advanced Renal Cell CarcinomaCompletedNCT01513187Phase 1/2
- IPI Biochemotherapy for Chemonaive Patients With Metastatic MelanomaTerminatedNCT01409174Phase 1
- Nordic Adjuvant IFN Melanoma TrialCompletedNCT01259934Phase 3
- Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein ProfilingCompletedNCT01217359Phase 1
- Evaluation of Interferon-Lovastatin Therapy for Malignant MelanomaWithdrawnNCT00963664Phase 2
- Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced NeoplasmCompletedNCT00908869Phase 1
- MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney CancerStatus unknownNCT00873236Phase 2
- Intron A for the Treatment of Hypertrophic ScarWithdrawnNCT00686478Phase 3
- Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced MalignanciesCompletedNCT00629200Phase 1
- Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 NonrespondersCompletedNCT00624325Phase 2/3
- Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected PatientsCompletedNCT00553930Phase 4
- Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-respondersCompletedNCT00538811Phase 2/3
- Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCCTerminatedNCT00522249Phase 1/2
- Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2aCompletedNCT00508040Phase 2
- Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage IIICompletedNCT00483132Phase 3
- Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by SurgeryStatus unknownNCT00471484Phase 2
- Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney CancerCompletedNCT00416429Phase 3
- High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCVCompletedNCT00381953Phase 3
- Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic MelanomaCompletedNCT00308607Phase 2
- 14 vs 24 Weeks HCV Treatment to Genotype 2/3 Patients With Rapid Virological ResponseCompletedNCT00308048Phase 3
- Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal CarcinomaWithdrawnNCT00293527Phase 2
- Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis BCompletedNCT00275938Phase 2/3
- Treatment With IFN After Curative Resection of HCC in HCV-Related CirrhosisCompletedNCT00273247Phase 3
- Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCCCompletedNCT00234182Phase 1/2
- Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha InterferonStatus unknownNCT00226408Phase 3
- Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral TreatmentCompletedNCT00226382Phase 4
- Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By SurgeryCompletedNCT00217542Phase 1
- Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)CompletedNCT00217373Phase 1
- Australian Trial in Acute Hepatitis CCompletedNCT00192569Phase 4
- Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyTerminatedNCT00176527Phase 2
- Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal DiseaseCompletedNCT00172809Phase 4
- Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)CompletedNCT00167583Phase 3
- Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral SuppressionTerminatedNCT00125814Phase 3
- Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00101114Phase 2
- Zidovudine Levels in HIV Infected Patients Being Treated for HCVCompletedNCT00059358Phase 1/2
- A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)CompletedNCT00008463Phase 2
- Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple MyelomaCompletedNCT00002556Phase 3
- A Phase II Efficacy Study of Roferon-A in Hairy Cell LeukemiaCompletedNCT00001567Phase 2
- A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency SyndromesCompletedNCT00001438Phase 2
- The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's SarcomaCompletedNCT00001114Phase 2
- The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV InfectionsCompletedNCT00001035Phase 1
- A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3CompletedNCT00000754Phase 2